.. Serment-de-galien, Recommandé par AAP : Pediatrics, Erreur ! Signet non défini, pp.592-596, 1975.

E. Abel, Opiates and Sex, Journal of Psychoactive Drugs, vol.105, issue.6, pp.205-221, 1984.
DOI : 10.1016/S0083-6729(08)61096-1

R. R. Abrahams, S. A. Kelly, S. Payne, P. N. Thiessen, J. Mackintosh et al., Rooming-in compared with standard care for newborns of mothers using methadone or heroin, Le médecin de famille canadien, pp.1722-1730, 2007.

E. Adalf, P. Begin, and E. Sawka, Enquête sur les toxicomanies au Canada (ETC) : Une enquête nationale sur la consommation d'alcool et d'autres drogues par les Canadiens, 2005.

C. Agence-de-la-santé-publique-du, http://www.phac-aspc.gc.ca/rhs-ssg/survey- enquete/mes-eem-1-fra.php, p.14, 2009.

A. Agthe, Clonidine as an Adjunct Therapy to Opioids for Neonatal Abstinence Syndrome: A Randomized, Controlled Trial, PEDIATRICS, vol.123, issue.5, pp.849-856, 2009.
DOI : 10.1542/peds.2008-0978

C. Algarin, P. Peirano, M. Garrido, F. Pizarro, and B. Lozoff, Iron Deficiency Anemia in Infancy: Long-Lasting Effects on Auditory and Visual System Functioning, Pediatric Research, vol.19, issue.2, pp.217-223, 2003.
DOI : 10.1203/01.PDR.0000047657.23156.55

M. E. Altink and D. I. Slaats-willemse, Effects of maternal and paternal smoking on attentional control in children with and without ADHD, European Child & Adolescent Psychiatry, vol.47, issue.9, pp.465-75, 2009.
DOI : 10.1007/s00787-009-0001-3

URL : https://hal.archives-ouvertes.fr/hal-00535134

J. C. Anderson, W. S. Mc-gee, R. Silva, and P. A. , DSM-III Disorders in Preadolescent Children, Archives of General Psychiatry, vol.44, issue.1, pp.69-76, 1987.
DOI : 10.1001/archpsyc.1987.01800130081010

S. Anderson, Trajectories of brain development: Point of vulnerability or window of opportunity? Neuroscience and Behavioral Reviews, pp.3-18, 2003.

R. Andres and M. Day, Perinatal complications associated with maternal tobacco use, Seminars in Neonatology, vol.5, issue.3, pp.231-272, 2000.
DOI : 10.1053/siny.2000.0025

R. Arlettaz, M. Kashiwagi, S. Das-kundu, J. Fauchere, A. Lang et al., Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources, Acta Obstetricia et Gynecologica Scandinavica, vol.21, issue.2, pp.145-50, 2005.
DOI : 10.1016/S0145-2134(99)00031-9

A. Arnsten, Genetics of Childhood Disorders: XVIII. ADHD, Part 2: Norepinephrine Has a Critical Modulatory Influence on Prefrontal Cortical Function, Journal of the American Academy of Child & Adolescent Psychiatry, vol.39, issue.9, pp.1201-1203, 2000.
DOI : 10.1097/00004583-200009000-00022

A. J. Lejeune and C. , Grossesse et consommation de drogues : comment contrôler les risques ? La Revue du Praticien Médecine Générale, pp.121-123, 2000.

M. Auriacombe and A. Loustaneau, Traitement médical de la femme enceinte héroïnomane ? Données de la littérature, Conseil de l'Europe, Grossesse et Toxicomanies, état des lieux en l'an, pp.45-83, 2000.

B. Bakstad, M. Sarfi, G. Welle-strand, and E. Et-ravndal, Opioid Maintenance Treatment during Pregnancy: Occurrence and Severity of Neonatal Abstinence Syndrome, European Addiction Research, vol.15, issue.3, pp.128-134, 2009.
DOI : 10.1159/000210042

C. Bauer, Périnatal effects of prenatal drug exposure. Neonatal aspects, Clin Périnatal, vol.26, pp.87-106, 1999.

N. Bayley, . Manuel-for-the-bayley, I. Scales, and . Development, Psychological Corporation Benningfield MM, et coll. Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women, Am J Addict, vol.19, issue.5, pp.416-437, 1969.

N. Benowitz and D. Dempsey, Pharmacotherapy for smoking cessation during pregnancy, Nicotine & Tobacco Research, vol.6, pp.189-202, 2004.
DOI : 10.1080/14622200410001669169

V. Bernstein and S. Hans, Predicting the Developmental Outcome of Two-Year-Old Children Born Exposed to Methadone: Impact of Social-Environmental Risk Factors, Journal of Clinical Child Psychology, vol.23, issue.4, pp.349-59, 1994.
DOI : 10.1207/s15374424jccp2304_1

A. Bhutta, M. Cleves, P. Casey, M. Cradock, and K. Anand, Cognitive and Behavioral Outcomes of School-Aged Children Who Were Born Preterm, JAMA, vol.288, issue.6, pp.728-737, 2002.
DOI : 10.1001/jama.288.6.728

J. Biederman, J. Rosenbaum, E. Bolduc-murphy, S. Faraone, and J. Chaloff, A 3-Year Follow-up of Children with and without Behavioral Inhibition, Journal of the American Academy of Child & Adolescent Psychiatry, vol.32, issue.4, pp.814-821, 1993.
DOI : 10.1097/00004583-199307000-00016

C. Blair, D. Granger, and R. P. Et-razza, Cortisol Reactivity Is Positively Related to Executive Function in Preschool Children Attending Head Start, Child Development, vol.149, issue.3, pp.554-567, 2005.
DOI : 10.1111/1467-8624.00047

J. Bouchez and C. Carlus, Lorsque l'enfant paraît Les traitements de substitution pour les usagers de drogues, pp.133-147, 1997.

. Bourquin, Méthadone à haut dosages et risque de torsade de pointe, 2002.

C. Boutet, L. Vercueil, C. Schelstraete, A. Buffin, and J. Legros, Ocytocin and maternal stress during the post-partum period. Annales d'Endocrinologie, pp.214-223, 2006.

C. Brems and L. Et-namyniuk, THE RELATIONSHIP OF CHILDHOOD ABUSE HISTORY AND SUBSTANCE USE IN AN ALASKA SAMPLE, Substance Use & Misuse, vol.28, issue.4, pp.473-494, 2002.
DOI : 10.1300/J070v08n02_02

A. Brisacier and C. Collin, Analyse des données de remboursement concernant l'échantillon généraliste des bénéficiaires en 2011, OFDT et ANSM, vol.10, p.14

S. Brogly, K. Saia, A. Walley, H. Du, and P. Sebastiani, Prenatal Buprenorphine Versus Methadone Exposure and Neonatal Outcomes: Systematic Review and Meta-Analysis, American Journal of Epidemiology, vol.180, issue.7, pp.673-86, 2014.
DOI : 10.1093/aje/kwu190

B. Hl, B. Ka, and D. Mahaffey, Methadone maintenance in pregnancy: a reappraisal, Am J Obstet Gynecol, vol.179, pp.459-63, 1998.

H. Bruehl, M. Rueger, I. Dziobek, V. Sweat, A. Tirsi et al., Hypothalamic-Pituitary-Adrenal Axis Dysregulation and Memory Impairments in Type 2 Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.7, pp.92-2439, 2007.
DOI : 10.1210/jc.2006-2540

R. Bullingham, H. Mcquay, and A. Moore, Buprenorphine kinetics, Clinical Pharmacology and Therapeutics, vol.28, issue.5, pp.667-72, 1980.
DOI : 10.1038/clpt.1980.219

A. Cadet-taïrou and S. Et-dambélé, Héroïne et autres opiacés Drogues et addictions, données essentielles, pp.242-250, 2013.

R. Calderon-margalit, C. Qiu, A. Ornoy, D. Siscovick, and M. Williams, Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy, Am J Obstet Gynecol, vol.201, pp.579-587, 2009.

B. Caravale, C. Tozzi, G. Albino, and S. Vicari, Cognitive development in low risk preterm infants at 3-4 years of age. Archives in Disease in Childhood Fetal and Neonatal Edition, pp.474-479, 2005.

C. H. Leonard, R. E. Piecuch, A. Bruce, and . Cooper, Use of the Bayley Infant Neurodevelopmental Screener With Low Birth Weight Infants, Journal of Pediatric Psychology, vol.26, issue.1, pp.33-40
DOI : 10.1093/jpepsy/26.1.33

R. Castel and A. Coppel, In Individus sous influence, Esprit, pp.237-256, 1991.

A. Cesbron, Intérêt de l'analyse du méconium pour évaluer l'exposition aux toxiques in utéro chez le nouveau-né. Application à l'étude de l'exposition aux traitements substitutifs aux opiacés au CHU de Caen, Th D Pharm Caen, pp.85-115, 2013.

V. Chefer, T. Czyzyk, E. Bolan, J. Moron, J. Pintar et al., Endogenous ??-Opioid Receptor Systems Regulate Mesoaccumbal Dopamine Dynamics and Vulnerability to Cocaine, Journal of Neuroscience, vol.25, issue.20, pp.5029-5066, 2005.
DOI : 10.1523/JNEUROSCI.0854-05.2005

V. Chefer and T. Shippenberg, Augmentation of Morphine-Induced Sensitization but Reduction in Morphine Tolerance and Reward in Delta-Opioid Receptor Knockout Mice, Neuropsychopharmacology, vol.24, issue.4, pp.887-98, 2009.
DOI : 10.1038/npp.2008.128

M. Cherkes-julkowski, Learning Disability, Attention-Deficit Disorder, and Language Impairment as Outcomes of Prematurity: A Longitudinal Descriptive Study, Journal of Learning Disabilities, vol.31, issue.3, pp.294-306, 1998.
DOI : 10.1177/002221949803100309

B. Cleary, J. Donnely, J. Stawbridge, P. Gallagher, T. Fahey et al., Methadone and perinatal outcomes: a retrospective cohort study, American Journal of Obstetrics and Gynecology, vol.204, issue.2, pp.139-148, 2011.
DOI : 10.1016/j.ajog.2010.10.004

J. Cofrancesco, N. Shah, K. G. Ghanem, A. S. Dobs, R. S. Klein et al., The effects of illicit drug use and HIV infection on sex hormone levels in women, Gynecological Endocrinology, vol.78, issue.1, pp.244-51, 2006.
DOI : 10.1001/archpsyc.57.2.141

C. Éditorial and . Uvmaf, Université visuelle Maïeutique Francophone) http://campus.cerimes.fr/maieutique/UE-sante-societe-humanite/protection_enfance/site/html/3.html, 2015.

. Conférence-de-consensus, . Anaes, C. Degiorgio, P. Fery, B. Polus et al., Stratégies thérapeutiques pour les personnes dépendantes des opiacés : place des traitements de substitution 23-24 juin 2004, Lyon CRAT-Centre de Référence sur les Agents Tératogènes Hospital Erasme Bruxelles, www.lecrat.org C.R.F.N, 2015.

C. Degiorgio, D. Van-den-berge, and A. Watelet, Comprendre la mémoire de travail à court terme, Hospital Erasme Bruxelles

C. For-substance-abuse and . Treatment, Medication-Assisted Treatment For Opioid Addiction in Opioid Treatment Programs (protocole d'amélioration du traitement nº 43, Rockville (MD), Substance Abuse and Mental Health Services Administration, 2005.

S. Curran, S. Purcell, I. Craig, P. Asherson, and P. Sham, The serotonin transporter gene as a QTL for ADHD, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol.56, issue.1, pp.42-47, 2005.
DOI : 10.1002/ajmg.b.30118

S. Dawe, P. Harnett, P. Straiger, and M. Dadds, Parent training skills and methadone maintenance: clinical opportunities and challenges, Drug and Alcohol Dependence, vol.60, issue.1, pp.1-11, 2000.
DOI : 10.1016/S0376-8716(00)80002-2

K. Debelak, W. Morrone, O. Grady, K. Jones, and H. , Buprenorphine???+???Naloxone in the Treatment of Opioid Dependence during Pregnancy-Initial Patient Care and Outcome Data, The American Journal on Addictions, vol.79, issue.3, pp.252-254, 2013.
DOI : 10.1111/j.1521-0391.2012.12005.x

D. Debruyne, T. Quentin, G. Poisnel, V. Lelong-boulouard, L. Barré et al., Acute and chronic administration of clorazepate modifies the cell surface regulation of ?? opioid receptors induced by buprenorphine in specific regions of the rat brain, Brain Research, vol.1052, issue.2, pp.222-231, 2005.
DOI : 10.1016/j.brainres.2005.06.027

J. M. Deglon and R. Et-imer, Methadone patients' sexual dysfunctions: Clinical and treatment issues, Heroin Addiction and Related Clinical Problems, vol.6, pp.17-26, 2004.

D. Devine and R. Wise, Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats, J Neurosci, vol.14, pp.1978-84, 1994.

D. Cubas, M. Field, and T. , Children of methadone-dependent women: Developmental outcomes., American Journal of Orthopsychiatry, vol.63, issue.2, pp.266-76, 1993.
DOI : 10.1037/h0079429

D. Montis, G. Devoto, P. Angioi, R. Curelli, V. Tagliamonte et al., In utero exposure to methadone produces a stable decrease of the cortex 5-HT transport system in rats, European Journal of Pharmacology, vol.90, issue.1, pp.57-63, 1983.
DOI : 10.1016/0014-2999(83)90213-3

D. Zegher, F. Van-den-berghe, G. Devlieger, H. Eggermont, E. Veldhuis et al., Dopamine Inhibits Growth Hormone and Prolactin Secretion in the Human Newborn, Pediatric Research, vol.34, issue.5, pp.642-645, 1993.
DOI : 10.1203/00006450-199311000-00016

D. Chiara, G. Bassareo, V. Fenu, S. , D. Luca et al., Dopamine and drug addiction: the nucleus accumbens shell connection, Neuropharmacology, vol.47, issue.1, pp.227-268, 2004.
DOI : 10.1016/j.neuropharm.2004.06.032

J. Dixon, B. Speidel, and J. Dixon, Neonatal flumazenil therapy reverses maternal diazepam, Acta Paediatrica, vol.152, issue.2, pp.225-231, 1998.
DOI : 10.1111/j.1651-2227.1998.tb00980.x

J. Dobbing, Vulnerable Periods in Developing Brain, Applied Neurochemistry, pp.287-316, 1968.
DOI : 10.1007/978-1-4471-1766-7_1

T. Doberczak, S. Kandall, and I. Wilets, Neonatal opiate abstinence syndrome in term and preterm infants, The Journal of Pediatrics, vol.118, issue.6, pp.933-937, 1991.
DOI : 10.1016/S0022-3476(05)82214-0

L. Dolovich, A. Addis, J. Vaillancourt, J. Power, G. Koren et al., Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies, BMJ, vol.317, issue.7162, pp.839-882, 1998.
DOI : 10.1136/bmj.317.7162.839

G. Döner, Hormone-dependant brain development, Psychoneuroendocrinology, vol.8, issue.2, pp.205-212, 1983.

E. Draper, J. Rankin, and A. Tonks, Recreational Drug Use: A Major Risk Factor for Gastroschisis?, American Journal of Epidemiology, vol.167, issue.4, pp.485-91, 2008.
DOI : 10.1093/aje/kwm335

D. Elia, M. Patenaude, J. Hamelin, C. Garrel, D. R. Bernier et al., No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters, Clinical Immunology, vol.109, issue.2, pp.179-187, 2003.
DOI : 10.1016/S1521-6616(03)00177-3

A. Eidelman, A. Nevet, B. Rudensky, R. Rabinowitz, C. Hammerman et al., The Effect of Meconium Staining of Amniotic Fluid on the Growth of Escherichia coli and Group B Streptococcus, Journal of Perinatology, vol.22, issue.6, pp.467-71, 2002.
DOI : 10.1038/sj.jp.7210774

E. Elefant, F. Bavoux, and C. Vauzelle-gardier, Psychotropes et grossesse, J Gynecol Obstet Biol Reprod, vol.29, pp.43-51, 2000.

E. K. Emory and M. K. Israelian, Prenatal cognitive development, Perspectives on fundamental processes in intellectual functioning 1998, pp.67-90

E. Enato, M. Moretti, and G. Koren, The fetal safety of benzodiazepines: an updates meta-analysis, J Obstet Gynecol Can, vol.33, pp.46-54, 2011.

J. Evans, J. Heron, H. Francomb, S. Oke, and J. Et-golding, Cohort study of depressed mood during pregnancy and after childbirth, BMJ, vol.323, issue.7307, pp.257-260, 2001.
DOI : 10.1136/bmj.323.7307.257

O. Fajemirkun-odudeyi, C. Sinha, and S. Tutty, Pregnancy outcome in women who use opiates, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.126, issue.2, pp.170-175, 2006.
DOI : 10.1016/j.ejogrb.2005.08.010

S. Faraone, R. Perlis, A. Doyle, J. Smoller, J. Goralnick et al., Molecular genetics of attention deficit/ hyperactivity disorder, Biol Psychiatry, vol.57, p.131323, 2005.

W. Farid, S. Dunlop, R. Tait, and G. Hulse, The Effects of Maternally Administered Methadone, Buprenorphine and Naltrexone on Offspring: Review of Human and Animal Data, Current Neuropharmacology, vol.6, issue.2, pp.125-50, 2008.
DOI : 10.2174/157015908784533842

A. Fattal-valevski, Y. Leitner, M. Kutai, E. Tal-posener, A. Tomer et al., Neurodevelopmental Outcome in Children With Intrauterine Growth Retardation: A 3-Year Follow-Up, Journal of Child Neurology, vol.14, issue.11, pp.14-724, 1999.
DOI : 10.1177/088307389901401107

R. Feldman and A. Weller, Evidence for a Neuroendocrinological Foundation of Human Affiliation, Psychological Science, vol.12, issue.11
DOI : 10.1038/nature03701

O. Ferrant, F. Papin, B. Clin, C. Lacroix, E. Saussereau et al., Fatal poisoning due to snorting buprenorphine and alcohol consumption, Forensic Science International, vol.204, issue.1-3, pp.1-3, 2011.
DOI : 10.1016/j.forsciint.2010.05.015

A. Ffa, Conférence de consensus : stratégies thérapeutiques pour les personnes dépendantes des opiacés : place des traitements de substitution -juin, 2004.

K. B. Fiks, H. L. Johnson, and T. S. Et-rosen, Methadone-Maintained Mothers: 3-Year Follow-Up of Parental Functioning, International Journal of the Addictions, vol.8, issue.1, pp.651-660, 1985.
DOI : 10.1300/J010v04n04_07

L. Finnegan, Consommation de drogues licites et illites pendant la grossesse : Répercussions sur la santé maternelle néonatale et infantile, 2013.

L. Finnegan, J. Emich, and J. Connangton, Abstinence score in the treatment of the infants of drug dependent mothers, Pediatr Res, vol.7, pp.319-326, 1973.

L. P. Finnegan, Neonatal abstinence syndrome: Assessment and pharmacotherapy, Neonatal therapy: An update, pp.122-146, 1986.

L. Finnegan, K. Kaltenbach-dans, R. A. Hoekelman, S. B. Friedman, and N. Nelson, Neonatal abstinence syndrome, Primary pediatric care, 2e éd., St. Louis (MO), Mosby, pp.1367-78, 1992.

L. Finnegan, S. R. Kandall, S. J. Aranda, and . Jaffe, Neonatal abstinence syndrome Neonatal and pediatric pharmacology: Therapeutic principles in practice, 2005.

G. Fischer, R. Ortner, K. Rohrmeister, R. Jagsch, A. Baewert et al., Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study, Addiction, vol.98, issue.2, pp.275-281, 2006.
DOI : 10.1111/j.1360-0443.2006.01321.x

S. Florin, I. Leroux-nicollet, J. Meunier, and J. Costentin, Autoradiographic localization of [3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain, Neuroscience Letters, vol.230, issue.1, pp.33-39, 1997.
DOI : 10.1016/S0304-3940(97)00470-9

A. Ghidini and C. Spong, Severe meconium aspiration syndrome is not caused by aspiration of meconium, American Journal of Obstetrics and Gynecology, vol.185, issue.4, pp.931-939, 2001.
DOI : 10.1067/mob.2001.116828

K. Gillogley, The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening, American Journal of Obstetrics and Gynecology, vol.163, issue.5, pp.1535-1577, 1990.
DOI : 10.1016/0002-9378(90)90621-D

V. Godding, C. Bonnier, and L. Fiasse, Does In Utero Exposure to Heavy Maternal Smoking Induce Nicotine Withdrawal Symptoms in Neonates?, Pediatric Research, vol.88, issue.7, pp.645-51, 2004.
DOI : 10.1203/01.PDR.0000112099.88740.4E

L. Goldschmidt, G. Richardson, and J. Willford, School achievement in 14-year-old youths prenatally exposed to marijuana, Neurotoxicology and Teratology, vol.34, issue.1, pp.2012161-167
DOI : 10.1016/j.ntt.2011.08.009

R. Gomez-flores and R. J. Weber, Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray, Immunopharmacology, vol.48, issue.2, pp.145-156, 2000.
DOI : 10.1016/S0162-3109(00)00198-3

G. Goodman, H. S. Cox, and S. , Attachment behavior and its antecedents in offspring born to methadone-maintained women, Journal of Clinical Child Psychology, vol.47, issue.1, pp.58-69, 1999.
DOI : 10.1207/s15374424jccp2801_5

B. A. Gosnell and D. D. Krahn, Taste and diet preferences as predictors of drug self-administration

K. Gouin, K. Murphy, and P. Shah, Effects of cocaine use during pregnancy on low birthweight and preterm birth, Am J Obset Gynecol, vol.204, pp.304-316, 2011.

W. Greenough, J. Black, and C. Wallace, Experience and Brain Development, Child Development, vol.58, issue.3, pp.539-559, 1987.
DOI : 10.2307/1130197

F. Grotenhermen, Pharmacokinetics and Pharmacodynamics of Cannabinoids, Clinical Pharmacokinetics, vol.134, issue.4, pp.327-60, 2003.
DOI : 10.2165/00003088-200342040-00003

N. Guedeney, C. Lamas, V. Bekhechi, A. S. Mintz, and A. Guedeney, D??veloppement du processus d???attachement entre un b??b?? et sa m??re, Archives de P??diatrie, vol.15, pp.12-19, 2008.
DOI : 10.1016/S0929-693X(08)73942-3

R. Haier, R. Jung, R. Yeo, K. Head, and M. Alkire, Structural brain variation and general intelligence, NeuroImage, vol.23, issue.1, pp.425-433, 2004.
DOI : 10.1016/j.neuroimage.2004.04.025

R. Hamilton, L. Mcglone, J. Mackinnon, H. Russel, M. Bradnam et al., Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy, British Journal of Ophthalmology, vol.94, issue.6, pp.696-700, 2010.
DOI : 10.1136/bjo.2009.169284

URL : https://hal.archives-ouvertes.fr/hal-00557336

M. Hayatbakhsh, V. Flenady, and K. Gibbons, Birth outcomes associated with cannabis use before and during pregnancy, Pediatric Research, vol.46, issue.2, pp.215-224, 2012.
DOI : 10.1038/pr.2011.25

E. Herlenius and H. Lagercrantz, Development of neurotransmitter systems during critical periods, Experimental Neurology, vol.190, pp.8-21, 2004.
DOI : 10.1016/j.expneurol.2004.03.027

C. A. Hernandez-avila, B. J. Rounsaville, and H. R. Et-kranzler, Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment, Drug and Alcohol Dependence, vol.74, issue.3, pp.265-272, 2004.
DOI : 10.1016/j.drugalcdep.2004.02.001

R. Herzlinger, S. Kandall, and H. Vaughan, Neonatal seizures associated with narcotic withdrawal, The Journal of Pediatrics, vol.91, issue.4, pp.638-641, 1977.
DOI : 10.1016/S0022-3476(77)80523-4

N. Hirose, K. Murakawa, K. Takada, Y. Oi, T. Suzuki et al., Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens, Neuroscience, vol.135, issue.1, pp.213-238, 2005.
DOI : 10.1016/j.neuroscience.2005.03.065

E. Hoder, J. Leckman, J. Poulsen, K. Caruso, R. Ehrenkranz et al., Clonidine treatment of neonatal narcotic abstinence syndrome, Psychiatry Research, vol.13, issue.3, pp.243-251, 1984.
DOI : 10.1016/0165-1781(84)90039-8

G. Hoegerman and S. Schnoll, Narcotic use in pregnancy, Clin Perinatol, vol.18, pp.51-76, 1991.

K. Hostettmamm, Tout savoir sur les plantes qui deviennent des drogues, Favre, pp.20-30, 2002.

M. Hudak and R. Tan, Neonatal Drug Withdrawal, PEDIATRICS, vol.129, issue.2, pp.540-60, 2012.
DOI : 10.1542/peds.2011-3212

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.365.9159

D. Hutcheson, H. Matthes, E. Valjent, P. Sánchez-blázquez, M. Rodríguez-díaz et al., Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice, European Journal of Neuroscience, vol.24, issue.1, pp.153-61, 2001.
DOI : 10.1016/0196-9781(96)00073-3

S. Iliodromiti, D. Mackay, G. Smith, J. Pell, and S. Nelson, Apgar Score and the Risk of Cause-specific Infant Mortality, Obstetric Anesthesia Digest, vol.35, issue.4, pp.1749-55, 2014.
DOI : 10.1097/01.aoa.0000472715.64951.49

. Inserm and F. Eustache, Neuropsychologie et neuroanatomie fonctionnelle de la mémoire humaine. http://www.inserm.fr/thematiques/neurosciences-sciences-cognitives-neurologie-psychiatrie/dossiersd-information/memoire, 2014.

S. Ip, Breastfeeding and Maternal and Infant Health Outcomes in Developed Countries, Agency for Healthcare Research and Quality, 2007.

B. Isemann, J. Meinzen-derr, and H. Akinbi, Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome, Journal of Perinatology, vol.112, issue.1, pp.25-29, 2011.
DOI : 10.1542/peds.2007-1182

S. Jaffee, K. Hanscombe, C. Haworth, O. Davis, and R. Plomin, Chaotic Homes and Children???s Disruptive Behavior, Psychological Science, vol.35, issue.6, pp.643-650, 2012.
DOI : 10.1093/bib/3.2.119

P. Jäkälä, J. Sirviö, J. Jolkkonen, R. Pjr, L. Acsady et al., The effects of p-chlorophenylalanine-induced serotinin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task, Behavioural Brain Research, vol.51, issue.1, pp.29-40, 1992.
DOI : 10.1016/S0166-4328(05)80309-2

M. Jauffret-roustide, L. Oudaya, M. Rondy, L. Strat, Y. Couturier et al., Représentations du traitement de l'hépatite C chez les usagers de drogues, Enquête InVS-ANRS Coquelicot Bull Epidemiol Hebd, pp.20-21213, 2004.

M. Jernite, B. Viville, B. Escande, J. P. Brettes, and J. Messer, Grossesse et bupr??norphine. ?? propos de 24 cas, Archives de P??diatrie, vol.6, issue.11, pp.1179-1185, 1999.
DOI : 10.1016/S0929-693X(00)86300-9

M. Jernite, B. Viville, and P. Diemunsch, Allaitement maternel et traitement substitutif par la buprénorphine, Arch Pédiatr, vol.7, pp.1014-1019, 2000.

S. Johnson and R. North, Opioids excite dopamine neurons by hyperpolarization of local interneurons

H. Jones, Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome, Drug and Alcohol Dependence, vol.79, issue.1, pp.1-10, 2005.
DOI : 10.1016/j.drugalcdep.2004.11.013

H. Jones, Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure, New England Journal of Medicine, vol.363, issue.24, pp.2320-2331, 2010.
DOI : 10.1056/NEJMoa1005359

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073631

H. Jones, G. Fischer, S. Heil, K. Kaltenbach, P. Martin et al., Maternal Opioid Treatment: Human Experimental Research (MOTHER)-approach, issues and lessons learned, Addiction, vol.9, pp.28-35, 2012.
DOI : 10.1111/j.1360-0443.2012.04036.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497510

H. Jones, L. Jansson, O. Grady, K. Kaltenbach, and K. , The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations, Neurotoxicology and Teratology, vol.39, pp.110-115, 2013.
DOI : 10.1016/j.ntt.2013.05.003

N. Jorgensen, E. Thurmann-nielsen, and R. Walstad, Pharmacokinetics and distribution of diazepam and oxazepam in early pregnancy, Acta Obstetricia et Gynecologica Scandinavica, vol.67, issue.6, pp.493-500, 1988.
DOI : 10.3109/00016348809029859

H. Joseph, S. Stancliff, and J. Et-langrod, Methadone maintenance treatment (MMT): A review of historical and clinical issues, Mount Sinai Journal of Medicine, vol.67, pp.347-364, 2000.

S. Kacinko, H. Jones, R. Johnson, R. Choo, and M. Huestis, Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium With Neonatal Outcomes, Clinical Pharmacology & Therapeutics, vol.62, issue.5, pp.604-616, 2008.
DOI : 10.1016/j.jchromb.2008.01.001

J. Kagan, The Concept of Behavioral Inhibition, pp.3-13, 1999.
DOI : 10.1093/acprof:oso/9780195118872.003.0001

J. Kakko, M. Heilig, and I. Sarman, Buprenorphine and methadone treatment of opiate dependence during pregnancy: Comparison of fetal growth and neonatal outcomes in two consecutive case series, Drug and Alcohol Dependence, vol.96, issue.1-2, pp.69-78, 2008.
DOI : 10.1016/j.drugalcdep.2008.01.025

H. Kalant, Opium revisited: a brief review of its nature, composition, non-medical use and relative risks, Addiction, vol.92, issue.3, 1997.
DOI : 10.1046/j.1360-0443.1997.9232673.x

A. Kalueff and D. Nutt, Role of GABA in memory and anxiety, Depression and Anxiety, vol.4, issue.3, pp.100-110, 1996.
DOI : 10.1002/(SICI)1520-6394(1996)4:3<100::AID-DA2>3.0.CO;2-K

S. Kamboj, L. Tookman, H. Jones, and . Curran, The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care, Pain, vol.117, issue.3, pp.388-395, 2005.
DOI : 10.1016/j.pain.2005.06.022

S. Kandall, S. Albin, J. Lowinson, B. Berle, A. Eidelman et al., Differential effects of maternal heroin and methadone use on birth weight, Pediatrics, vol.58, pp.681-685, 1976.

S. Kandall, T. Doberczak, K. Mauer, R. Strashun, and D. Korts, Opiate vs CNS depressant therapy in neonatal drug abstinence syndrome, Am Journal of Diseases of Children, vol.137, pp.378-82, 1983.

K. Sr, D. Tm, M. Jantunen, and J. Stein, The methadone maintained pregnancy, Clin Perinatol, vol.26, pp.173-83, 1999.

S. Kandall, Treatment strategies for drug-exposed neonates, Clin Perinatol, vol.26, pp.231-274, 1999.

K. Kendler, K. Sundquist, H. Ohlsson, K. Palmér, and H. Maes, Genetic and Familial Environmental Influences on the Risk for Drug Abuse, Archives of General Psychiatry, vol.69, issue.7, pp.690-697, 2012.
DOI : 10.1001/archgenpsychiatry.2011.2112

C. Khun, D. Ignar, and R. Windh, Endocrine function as target of perinatal drug effects: Methodologic issues, pp.206-232, 1991.
DOI : 10.1037/e496212006-018

P. Kintz, Deaths involving buprenorphine: a compendium of French cases, Forensic Science International, vol.121, issue.1-2, pp.65-69, 2001.
DOI : 10.1016/S0379-0738(01)00454-6

P. Kintz, A new series of 13 buprenorphine-related deaths, Clinical Biochemistry, vol.35, issue.7, pp.513-516, 2002.
DOI : 10.1016/S0009-9120(02)00304-1

K. Kivistö, H. Alapulli, S. Tupola, S. Alaluusua, and S. Kivitie-kallio, Dental health of young children prenatally exposed to buprenorphine. A concern of child neglect?, European Archives of Paediatric Dentistry, vol.49, issue.3, pp.197-202, 2014.
DOI : 10.1007/s40368-013-0095-7

M. H. Klaus, Mother and infant: early emotional ties, Pediatrics, vol.102, issue.5, pp.1244-1290, 1998.

A. Kolar, B. Brown, C. Haertzen, and B. Michaelson, Children of Substance Abusers: The Life Experiences of Children of Opiate Addicts in Methadone Maintenance, The American Journal of Drug and Alcohol Abuse, vol.4, issue.2, pp.159-171, 1994.
DOI : 10.3109/00952999409106780

C. Konijnenberg and A. Melinder, Neurodevelopmental investigation of the mirror neurone system in children of women receiving opioid maintenance therapy during pregnancy, Addiction, vol.41, issue.1, pp.154-60, 2012.
DOI : 10.1111/j.1360-0443.2012.04006.x

C. Konijnenberg and A. Melinder, Executive function in preschool children prenatally exposed to methadone or buprenorphine, Child Neuropsychology, vol.59, issue.5, pp.1-16, 2014.
DOI : 10.1080/1363849021000041891

G. Koob, L. Moal, and M. , Drug Abuse: Hedonic Homeostatic Dysregulation, Science, vol.278, issue.5335, pp.52-60, 1997.
DOI : 10.1126/science.278.5335.52

W. K. Kraft, Sublingual Buprenorphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Trial, PEDIATRICS, vol.122, issue.3, pp.601-607, 2008.
DOI : 10.1542/peds.2008-0571

M. Kushner, . Wall, . Krueger, . Sher, P. Maurer et al., Alcohol Dependence is Related to Overall Internalizing Psychopathology Load Rather than to Particular Internalizing Disorders: Evidence from a National Sample, Alcoholism: Clinical and Experimental Research, vol.119, issue.2, pp.325-356, 2012.
DOI : 10.1111/j.1530-0277.2011.01604.x

I. Lacroix, A. Berrebi, D. Garipuy, L. Schmitt, Y. Hammou et al., Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study, European Journal of Clinical Pharmacology, vol.87, issue.1, pp.1053-1062, 2011.
DOI : 10.1007/s00228-011-1049-9

S. Langenfeld, . Birkenfeld, C. Herkenrath, M. Müller, M. Hellmich et al., Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops, Drug and Alcohol Dependence, vol.77, issue.1, pp.31-36, 2005.
DOI : 10.1016/j.drugalcdep.2004.07.001

X. Laqueille, C. Launay, A. Dervaux, and M. Kanit, Abus d'alcool et de benzodiazépines lors des traitements de substitution chez l'héroïnomane, p.225, 2009.

C. G. Last, M. Hersen, A. Kazdin, H. Orvaschel, and S. Perrin, Anxiety Disorders in Children and Their Families, Archives of General Psychiatry, vol.48, issue.10, pp.928-934, 1991.
DOI : 10.1001/archpsyc.1991.01810340060008

J. Lauder and U. Schambra, Morphogenetic roles of acetylcholine, Environmental Health Perspectives, vol.107, issue.Suppl 1, pp.65-69, 1999.
DOI : 10.1289/ehp.99107s165

P. Law, Y. Wong, and H. Loh, Molecular Mechanisms and Regulation of Opioid Receptor Signaling, Annual Review of Pharmacology and Toxicology, vol.40, issue.1
DOI : 10.1146/annurev.pharmtox.40.1.389

M. La, Plan gouvernemental de lutte contre les drogues et les conduites addictives 2013- 2017-http://www.drogues.gouv.fr/site-professionnel/la-mildeca/plan-gouvernemental/plan- gouvernemental, 2013.

Y. Leitner, A. Fattal-valevski, R. Geva, H. Bassan, E. Posner et al., Six-Year Follow-Up of Children With Intrauterine Growth Retardation: Long-Term, Prospective Study, Journal of Child Neurology, vol.15, issue.12, pp.15-781, 2000.
DOI : 10.1177/088307380001501202

C. Lejeune, J. Ropert, and S. Montamat, Devenir médico-social de 59 nouveau-nés de mère toxicomane, J Gynecol Obstet Biol Reprod, vol.26, pp.395-404, 1997.

C. Lejeune, Périnatalité et précarité, réduire les risques grâce aux réseaux ville-hôpital, 1998.

C. Lejeune, ??volution des modalit??s de prise en charge des femmes enceintes toxicomanes et de leurs enfants. Groupe d'??tudes grossesse et addictions (GEGA), Archives de P??diatrie, vol.7, issue.2, pp.283-287, 2000.
DOI : 10.1016/S0929-693X(00)80072-X

C. Lejeune, L. Simmat-durand, L. Gourarier, and S. Aubisson, Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution, Drug and Alcohol Dependence, vol.82, issue.3, pp.250-257, 2006.
DOI : 10.1016/j.drugalcdep.2005.10.001

C. Lejeune, Protocole de soin pour le syndrome de sevrage néonatal après exposition in utero aux opiacés, 2011.

B. M. Lester, E. Z. Et, and . Tronick, The NICU Network Neurobehavioral Scale [manuscrit non publié, Providence (RI), 1993.

. Le-monde, La pratique de l'allaitement varie fortement en fonction du niveau social de mères

N. Lintzeris, T. Mitchell, A. Bond, L. Nestor, and J. Strang, Interactions on Mixing Diazepam With Methadone or Buprenorphine in Maintenance Patients, Journal of Clinical Psychopharmacology, vol.26, issue.3, pp.274-83, 2006.
DOI : 10.1097/01.jcp.0000219050.33008.61

A. Liu, S. Sithamparanatham, M. Jones, C. Cook, and R. Nanan, Growth restriction in pregnancies of opioid-dependent mothers, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.95, issue.4, pp.258-62, 2010.
DOI : 10.1136/adc.2009.163105

M. Loilier, M. Fiant, B. Guillois, and A. Coquerel, Protocole SUBOPGEST : Valeur pronostique du dosage des traitements de substitution aux opiacés (buprénorphine et méthadone) dans le méconium pour évaluer le délai, la durée et l'intensité du SSNN, 2010.

J. Lorden, E. Rickert, and D. Berry, Forebrain monoamines and associative learning: I. Latent inhibition and conditioned inhibition, Behavioural Brain Research, vol.9, issue.2, pp.181-199, 1983.
DOI : 10.1016/0166-4328(83)90127-4

H. Ludington and A. Hadeed, Energy conservation in preterm infants during skin to skin care, 1990.

K. Lutfy and . Cowan, Buprenorphine: A Unique Drug with Complex Pharmacology, Current Neuropharmacology, vol.2, issue.4, pp.395-402, 2004.
DOI : 10.2174/1570159043359477

K. Macdonald and T. Macdonald, The Peptide That Binds, Harvard Review of Psychiatry, vol.18, issue.1, pp.1-21, 2010.
DOI : 10.3109/10673220903523615

R. Madgula, T. Groshkova, and S. Mayet, Illicit drug use in pregnancy: effects and management, Expert Review of Obstetrics & Gynecology, vol.6, issue.2, pp.179-92, 2011.
DOI : 10.1586/eog.10.54

J. Mccarthy and B. Posey, Methadone Levels in Human Milk, Journal of Human Lactation, vol.20, issue.2, pp.115-135, 2000.
DOI : 10.1177/089033440001600206

P. Mcelhatton, D. Bateman, C. Evans, K. Pughe, and S. Thomas, Congenital anomalies after prenatal ecstasy exposure, The Lancet, vol.354, issue.9188, pp.1441-1443, 1999.
DOI : 10.1016/S0140-6736(99)02423-X

B. Mcewan and R. M. Sapolsky, Stress and cognitive function, Current Opinion in Neurobiology, vol.5, issue.2, pp.205-216, 1995.
DOI : 10.1016/0959-4388(95)80028-X

B. Mcewen, Brain on stress: How the social environment gets under the skin, Proceedings of the National Academy of Sciences, vol.109, issue.Supplement_2, pp.17180-17185
DOI : 10.1073/pnas.1121254109

J. Mcginty and D. Ford, Effects of Prenatal Methadone on Rat Brain Catecholamines, Developmental Neuroscience, vol.3, issue.4-6, pp.224-234, 1980.
DOI : 10.1159/000112395

E. Meier, I. Hertz, and A. Schousboe, Neurotransmitters as developmental signals, Neurochemistry International, vol.19, issue.1-2, pp.1-15, 1991.
DOI : 10.1016/0197-0186(91)90113-R

E. Meites, Opiate Exposure in Breastfeeding Newborns, Journal of Human Lactation, vol.76, issue.1, p.13, 2007.
DOI : 10.1177/0890334406297263

A. Melinder, C. Konijnenberg, and M. Sarfi, Deviant smooth pursuit in preschool children exposed prenatally to methadone or buprenorphine and tobacco affects integrative visuomotor capabilities, Addiction, vol.8, issue.12, pp.2175-82, 2013.
DOI : 10.1111/add.12267

L. Ministère-de and . Justice, Enfants victimes d'infractions pénales : guide de bonnes pratiques Du signalement au procès pénal, des Affaires Criminelles et des Grâces, 2003.

C. Mollereau, M. Parmentier, P. Mailleux, J. Butour, C. Moisand et al., ORL1, a novel member of the opioid receptor family, FEBS Letters, vol.73, issue.1, pp.33-41, 1994.
DOI : 10.1016/0014-5793(94)80235-1

C. Monk, S. Webb, and C. Nelson, Prenatal Neurobiological Development: Molecular Mechanisms and Anatomical Change, Developmental Neuropsychology, vol.6, issue.2, pp.211-236, 2001.
DOI : 10.1038/376331a0

Z. Nagy, H. Westerber, and T. Klingberg, Maturation of White Matter is Associated with the Development of Cognitive Functions during Childhood, Journal of Cognitive Neuroscience, vol.10, issue.7, pp.1227-1233
DOI : 10.1097/00004728-199501000-00005

E. Nestler, Molecular basis of long-term plasticity underlying addiction, Nature Reviews Neuroscience, vol.34, issue.2, pp.119-128, 2001.
DOI : 10.1038/35053570

I. Nulman, J. Gladstone, G. Koren, O. Hayon, and B. , Fetal alcohol syndrome

O. Drogues, Indicateurs et tendances Nouveaux produits de synthèse et internet, pp.368-382, 2002.

A. Ornoy, J. Segal, R. Bar-hamburger, and C. Greenbaum, Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors, Developmental Medicine & Child Neurology, vol.92, issue.10, pp.668-675, 2001.
DOI : 10.1111/j.1469-8749.2001.tb00140.x

D. Osborn, M. Cole, and H. Jeffery, Opiate treatment for opiate withdrawal in newborn infants

D. Osborn, H. Jeffery, and M. Cole, Sedatives for opiate withdrawal in newborn infants, Cochrane Database Syst Rev, issue.3, p.2053, 2002.

O. 'keeffe, M. J. O-'callaghan, M. Williams, G. M. Najman, J. M. Et-bor et al., Learning, Cognitive, and Attentional Problems in Adolescents Born Small for Gestational Age, PEDIATRICS, vol.112, issue.2, pp.301-307, 2003.
DOI : 10.1542/peds.112.2.301

R. Parikh, T. Hussain, G. Holder, A. Bhoyar, and A. Ewer, Maternal methadone therapy increaced QTc interval in newborn infants, Arch Dis Child Fetal Neonatla, vol.96, 2011.

M. Parrino and C. Junet, Traitement à la méthadone, US Department of Health, traduction Editions Médecine et Hygiène, p.320, 1994.

R. N. Pechnick, Effects of Opioids on the Hypothalamo-Pituitary-Adrenal Axis, Annual Review of Pharmacology and Toxicology, vol.33, issue.1, pp.353-382, 1993.
DOI : 10.1146/annurev.pa.33.040193.002033

E. Pennings, A. Leccese, and F. Wolff, Effects of concurrent use of alcohol and cocaine, Addiction, vol.22, issue.7, pp.773-83, 2002.
DOI : 10.1016/S0047-2352(97)00082-2

C. M. Pepper and H. G. , Opiates and opioid peptides hyperpolarize locus coeruleus neurons in vitro, Science, vol.209, issue.4454, pp.394-396, 1980.
DOI : 10.1126/science.7384811

C. Pert and S. Snyder, Opiate Receptor: Demonstration in Nervous Tissue, Science, vol.179, issue.4077, pp.1011-1025, 1973.
DOI : 10.1126/science.179.4077.1011

K. Pickett, L. Waschlag, L. Dai, and B. Leventhal, Fluctuations of maternal smoking during pregnancy

J. Prosser, L. Cohen, M. Steinfeld, D. Eisenberg, E. London et al., Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment, Drug and Alcohol Dependence, vol.84, issue.3, pp.240-247, 2006.
DOI : 10.1016/j.drugalcdep.2006.02.006

I. Rapport-conjoint and . En, education.gouv.fr/cid1963/les-dispositifs- passerelles-de-la-famille-et-du-lieu-de-garde-a-l-ecole-maternelle.html Rapport national, 2000.

C. Rees, Thinking about children's attachements, Arch DisChild, vol.90, 2005.

A. Represa and Y. Et-ben-ari, Trophic actions of GABA on neuronal development, Trends in Neurosciences, vol.28, issue.6, pp.278-283, 2005.
DOI : 10.1016/j.tins.2005.03.010

URL : https://hal.archives-ouvertes.fr/inserm-00484557

«. Réseau, ». Sécurité-naissance, B. Branger, C. Flamant, and S. Brehu, Recommandations sur la prise en charge d'un syndrome de sevrage des opiacés maternels chez un nouveau-né

. Rizzolatti, conférence donnée à l'Académie des sciences, déc, 2006.

S. Robinson, J. Maher, M. Wallace, and P. Kunko, Perinatal Methadone Exposure Affects Dopamine, Norepinephrine, and Serotonin in the Weanling Rat, Neurotoxicology and Teratology, vol.19, issue.4, pp.295-303, 1997.
DOI : 10.1016/S0892-0362(97)00018-4

S. Robinson, Effect of prenatal opioid exposure on cholinergic development, Journal of Biomedical Science, vol.56, issue.suppl, 2000.
DOI : 10.1007/BF02255474

S. Robinson, Effects of perinatal buprenorphine and methadone exposures on striatal cholinergic ontogeny, Neurotoxicology and Teratology, vol.24, issue.2, pp.137-142, 2001.
DOI : 10.1016/S0892-0362(01)00185-4

B. Roques, F. Noble, V. Daugé, M. Fournié-zaluski, and A. Beaumont, Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology, Pharmacol Rev, vol.45, pp.87-146, 1993.
URL : https://hal.archives-ouvertes.fr/hal-00314275

B. Roques, La dangerosité des drogues, p.316, 1999.

T. S. Rosen and H. L. Et-johnson, Long term effects of prenatal methadone maintenance, Current research on the consequences of maternal drug abuse, pp.73-83, 1985.
DOI : 10.1037/e496932006-007

M. D. Rockville, National institute on Drug abuse Roth-Deri I, Green-Sadan I, Yadid G. Beta-endorphin and drug-induced reward and reinforcement

J. Roy, R. Toubin, E. Mazurier, C. Chanal, M. Misraoui et al., Developmental outcomes of 5-year-old children born to opiate-dependant mothers: Effects of a multidisciplinary intervention during pregnancy, 2011.

A. Saive and . Guedeney, The role of oxytocin in the caregiving behaviour of mothers of infants, 2011.

S. Salo, K. Kivistö, R. Korja, Z. Biringen, S. Tupola et al., Emotional Availability, Parental Self-Efficacy Beliefs, and Child Development in Caregiver-Child Relationships with Buprenorphine-Exposed 3-year-olds, Parenting, vol.26, issue.3-4, pp.244-259, 2009.
DOI : 10.1080/14616730050085536

E. Sanchez, J. Bigbee, W. Fobbs, S. Robinson, and C. Sato-bigbee, Opioid addiction and pregnancy: Perinatal exposure to buprenorphine affects myelination in the developing brain, Glia, vol.18, issue.9, pp.1017-1044, 2008.
DOI : 10.1002/glia.20675

S. Canada, Enquête de surveillance de l'usage du tabac au Canada (ESUTC) http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche, 2011.

M. Sarfi, J. Sundet, and H. Waal, Maternal stress and behavioral adaptation in methadone- or buprenorphine-exposed toddlers, Infant Behavior and Development, vol.36, issue.4, pp.707-723, 2013.
DOI : 10.1016/j.infbeh.2013.08.006

J. Schmittner, J. R. Schroeder, D. H. Epstein, and K. L. Preston, Menstrual cycle length during methadone maintenance, Addiction, vol.13, issue.6, pp.829-865, 2005.
DOI : 10.1111/j.1360-0443.2005.01091.x

N. S. Seligman, N. Salva, E. J. Hayes, K. C. Dysart, P. E. Baxter et al., Predicting lenght of treatment for NAS in methadone-exposed neonates, Am. J. Obstet. Gynecol, vol.199, pp.396-397, 2008.

N. Seligman, D. Almario, E. Hayes, K. Dysart, V. Berghella et al., Relationship between Maternal Methadone Dose at Delivery and Neonatal Abstinence Syndrome, The Journal of Pediatrics, vol.157, issue.3, 2010.
DOI : 10.1016/j.jpeds.2010.03.033

M. Shinderman and S. Maxwell, Sexual dysfunction associated with methadone maintenance: Treatment with bromocryptine, Heroin Addiction and Related Clinical Problems, vol.2, pp.9-14, 2000.

. Shippenbergts, A. Zapata, and V. Chefer, Dynorphin and the pathophysiology of drug addiction

L. Simmat-durand, Maternités à risque : signalements et placements des enfants de mère toxicomane, 2005.

J. Sirviö, P. Riekkinen, P. Jäkälä, and P. J. Et-riekkinen, Experimental studies on the role of serotonin in cognition, Progress in Neurobiology, vol.43, issue.4-5, pp.363-379, 1994.
DOI : 10.1016/0301-0082(94)90060-4

S. Soepatmi, Developmental outcomes of children of mothers dependant on heroin or heroin/methadone during pregnancy, Acta Paediatrica Supplement, vol.404, pp.36-39, 1994.

L. Squire, Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans., Psychological Review, vol.99, issue.2, pp.195-231, 1992.
DOI : 10.1037/0033-295X.99.2.195

C. Stahle, F. Melchert, and M. Weigel, Investigation of foetal heart-rate pattern that shows a reduced oscillation amplitude, Geburthshile Neonatal, vol.207, pp.110-113, 2003.

S. Stine, C. Grillon, C. Morgan, T. Kosten, D. Charney et al., Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine, Psychopharmacology, vol.154, issue.3, pp.274-281, 2001.
DOI : 10.1007/s002130000644

V. Sundelin-wahlsten and I. Sarman, Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy, Acta Paediatrica, vol.57, issue.141, pp.544-553, 2013.
DOI : 10.1111/apa.12210

M. J. Taylor and D. L. Mcculloch, Visual Evoked Potentials in Infants and Children, Journal of Clinical Neurophysiology, vol.9, issue.3, pp.357-372, 1992.
DOI : 10.1097/00004691-199207010-00004

D. Thajam, D. Atkinson, C. Sibley, and T. Lavender, Is Neonatal Abstinence Syndrome Related to the Amount of Opiate Used?, Journal of Obstetric, Gynecologic & Neonatal Nursing, vol.39, issue.5, pp.503-512, 2010.
DOI : 10.1111/j.1552-6909.2010.01174.x

B. Thompson, P. Levitt, and G. Stanwood, Prenatal exposure to drugs: effects on brain development and implications for policy and education, Nature Reviews Neuroscience, vol.133, issue.4, pp.303-312, 2009.
DOI : 10.1016/0166-2236(95)93934-P

R. Todd, Neural development is regulated by classical neurotransmitters: Dopamine D2 receptor stimulation enhances neurite outgrowth, Biological Psychiatry, vol.31, issue.8, pp.794-807, 1992.
DOI : 10.1016/0006-3223(92)90311-M

S. Tough, K. Tofflemire, M. Clarke, and C. Newburn-cook, Do Women Change Their Drinking Behaviors While Trying to Conceive? An Opportunity for Preconception Counseling, Clinical Medicine & Research, vol.4, issue.2, pp.97-105, 2006.
DOI : 10.3121/cmr.4.2.97

A. Tracqui and B. Ludes, Médicaments psychotropes, Toxicologie et pharmacologie médicolégales, pp.233-274, 1998.

M. Traité-d-'addictologie and . Reynaud, Flammarion médecine-sciences, pp.1-800, 2006.

D. Turck, M. Vidailhet, A. Bocquet, J. Bresson, . Briend et al., Allaitement maternel : les b??n??fices pour la sant?? de l???enfant et de sa m??re, Archives de P??diatrie, vol.20, issue.2, pp.29-48, 2013.
DOI : 10.1016/S0929-693X(13)72251-6

U. Jg and H. Szeto, Precipitated opiate abstinence in utero, Am J Obstet Gynecol, vol.151, pp.441-445, 1985.

S. Uysal, Y. Renda, M. Topcu, G. Erdem, and R. Karacan, Evoked potentials in full-term and premature infants: a comparative study, Child's Nervous System, vol.4, issue.2, pp.88-92, 1993.
DOI : 10.1007/BF00305314

M. Velez, L. Jansson, J. Scroeder, and E. Williams, Prenatal Methadone Exposure and Neonatal Neurobehavioral Functioning, Prenatal methadone exposure and neonatal neurobehavioral functioning, pp.704-713, 2009.
DOI : 10.1203/PDR.0b013e3181bc035d

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796281

A. Van-baar and B. Et-de-graaff, Cognitive development at preschool-age of infants of drug-dependent mothers. Developmental Medicine and Child Neurology, pp.1063-1875, 1994.

R. Voigt, Concurrent and Predictive Validity of the Cognitive Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS) and the Mental Developmental Index of the Bayley Scales of Infant Development, Clinical Pediatrics, vol.42, issue.5, pp.427-459, 2003.
DOI : 10.1177/000992280304200507

E. Wachman, . Byun, and . Philipp, Breastfeeding Rates Among Mothers of Infants with Neonatal Abstinence Syndrome, Breastfeeding Medicine, vol.5, issue.4, pp.159-164, 2010.
DOI : 10.1089/bfm.2009.0079

K. Walhovd, V. Moe, K. Slinning, P. Due-tonnessen, A. Bjornerud et al., Volumetric cerebral characteristics of children exposed to opiates and other substances in utero, NeuroImage, vol.36, issue.4, pp.1331-1375, 2007.
DOI : 10.1016/j.neuroimage.2007.03.070

S. Walsh, K. Preston, M. Stitzer, E. Cone, and G. Bigelow, Clinical Pharmacology of Buprenorphine, Survey of Anesthesiology, vol.39, issue.1, pp.569-80, 1994.
DOI : 10.1097/00132586-199502000-00012

J. Ward, W. Hall, and R. Mattick, Role of maintenance treatment in opioid dependence, The Lancet, vol.353, issue.9148, pp.221-227, 1999.
DOI : 10.1016/S0140-6736(98)05356-2

S. M. Weiner, L. P. Et, and . Finnegan, Drug withdrawal in the neonate Handbook of Neonatal Intensive Care, 6e éd, 2010.

G. Welle-strand, S. Skurtveit, H. Jones, H. Waal, B. Bakstad et al., Neonatal outcomes following in utero exposure to methadone or buprenorphine: A National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009, Drug and Alcohol Dependence, vol.127, issue.1-3, pp.200-206, 1996.
DOI : 10.1016/j.drugalcdep.2012.07.001

G. Wenk, D. Hughey, V. Boundy, A. Kim, L. Walker et al., Neurotransmitters and memory: Role of cholinergic, serotonergic, and noradrenergic systems., Behavioral Neuroscience, vol.101, issue.3, pp.325-332, 1987.
DOI : 10.1037/0735-7044.101.3.325

A. Whitelaw, G. Heisterkamp, K. Sleath, A. Acolet, and M. Richards, Skin to skin contact for very low birthweight infants and their mothers., Archives of Disease in Childhood, vol.63, issue.11, pp.1377-1380, 1988.
DOI : 10.1136/adc.63.11.1377

N. Whitham, J. Spurrier, G. Sawyer, A. Baghurst, E. Taplin et al., The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials, Neurotoxicology and Teratology, vol.32, issue.2, pp.280-308, 2010.
DOI : 10.1016/j.ntt.2009.09.001

M. Whittmann, A Comparison of the Effects of Single- and Split-Dose Methadone Administration on the Fetus: Ultrasound Evaluation, International Journal of the Addictions, vol.122, issue.2, pp.213-218, 1991.
DOI : 10.3109/10826089109053183

W. Pl, V. Dorato, M. Wr, and C. Lb, Benzodiazepine and methadone use is associated with longer neonatal withdrawal in poly-substance exposed infants, Am J Obstet Gynecol, vol.182, p.177, 2000.

K. Wojnar-horton-re, . Jh, and P. Yapp, Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme, British Journal of Clinical Pharmacology, vol.44, issue.6, pp.543-550, 1997.
DOI : 10.1046/j.1365-2125.1997.t01-1-00624.x

S. Wong, A. Ordean, and M. Kahan, Substance Use in Pregnancy, Journal of Obstetrics and Gynaecology Canada, vol.33, issue.4, pp.367-84, 2011.
DOI : 10.1016/S1701-2163(16)34855-1

T. Wouldes and L. Woodward, Maternal methadone dose during pregnancy and infant clinical outcome, Neurotoxicology and Teratology, vol.32, issue.3, pp.406-419, 2010.
DOI : 10.1016/j.ntt.2010.01.007

W. Xie, Y. He, Y. Yang, Y. Li, K. Kang et al., Disruption of Cdk5-associated phosphorylation of residue threonine-161 of the delta-opioid receptor: impaired receptor function and attenuated morphine antinociceptive tolerance, J Neurosci, vol.29, p.355164, 2009.

J. Zadina, L. Hackler, L. Ge, and A. Kastin, A potent and selective endogenous agonist for the ??-opiate receptor, Nature, vol.386, issue.6624, pp.499-502, 1997.
DOI : 10.1038/386499a0

I. Zagon and P. Mclaughlin, PERINATAL METHADONE EXPOSURE AND BRAIN DEVELOPMENT: A BIOCHEMICAL STUDY, Journal of Neurochemistry, vol.33, issue.1, pp.49-54, 1978.
DOI : 10.1111/j.1471-4159.1964.tb07499.x

T. Zdravkovic, O. Genbacev, M. Mcmaster, and S. Fisher, The adverse effects of maternal smoking on the human placenta: A review, Placenta, vol.26, pp.81-87, 2005.
DOI : 10.1016/j.placenta.2005.02.003

H. Zeilhofer and G. Calò, Nociceptin/Orphanin FQ and Its Receptor--Potential Targets for Pain Therapy?, Journal of Pharmacology and Experimental Therapeutics, vol.306, issue.2, pp.423-452, 2003.
DOI : 10.1124/jpet.102.046979